AB Biotek Acquires Spanish Biomedical DR Healthcare
Respective leaders in fermentation science and DAO-based medical nutrition join together to focus on innovative enzyme-based solutions for the human nutrition & health market.
PETERBOROUGH, United Kingdom, May 26, 2021
We are a Biomedical Company specialized in Medical Nutrition.
Founded in 2007 in Barcelona, we manufacture, research, develop, innovate, market and carry out licensing -out of new nutraceutical products, functional foods, active ingredients and customized solutions.
Our great value is research and we firmly believe in the “Enterprise-University” alliance, developing our activities in two R&D centers.
DR Healthcare is a business unit de AB Biotek. For more information access to www.abbiotek.com.
Nutraceuticals and diagnosis
From our production plant we offer our nutraceutical products in different gastro-resistant formats (tablets, pellets, micropellets, capsules, microcapsules and nanocapsules), facilitating the adaptation to the current regulation of each market and its commercialization at international level.
Manufacturing for third parties
We make available to pharmaceutical and food companies that are looking for a reliable supplier, the highest levels of quality, regulatory support and production of Diamine Oxidase, manufactured in our enzyme production plant located in Tarragona (Spain).
The production of this ADI (Active Dietary Ingredient) is vertically integrated so it is able to control the intermediates of its manufacturing.
DR Healthcare stands out as a leading company in the production of Diamino Oxidasa, which allows us to offer tailored solutions for use in the veterinary, animal health and food sectors.
Our solutions based on Diamino Oxidase are adapted to the new food control standards, which stipulate the control of histamine levels in order to avoid risks of poisoning due to the consumption of large amounts of this biogenic amine present in food.
Veterinary and animal health sector
DAO deficiency specialists
DAO deficiency is an alteration in the metabolism of food histamine that occurs when there is little activity of the enzyme Diamino Oxidase (DAO). DAO is the main enzyme in the metabolism of exogenous histamine and develops its functional activity in the intestine.
Since there is a disproportion between the histamine ingested or released by the cells that store it in the body, and the ability to metabolize it, the accumulation of histamine in plasma and the appearance of adverse effects occurs.
Main symptoms of DAO deficiency
Migraine, fibromyalgia, irritable bowel syndrome (SCI) and attention deficit hyperactivity disorder (ADHD) are the symptoms with the highest prevalence in the population caused by DAO deficiency.
Press releases and media’s news
Scientific and clinical evidence in DAO deficiency
Association of Diamine oxidase (DAO) variants with the risk for migraine from North Indian population
Activities and events